{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:02:35Z","timestamp":1789056155771,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.xagr.2024.100416","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T07:43:39Z","timestamp":1730533419000},"page":"100416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Maternal and neonatal outcomes following antenatal corticosteroids in pregnancies complicated by diabetes: a scoping review"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5210-1907","authenticated-orcid":false,"given":"Klea","family":"Atallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Lynn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalynn","family":"Pszczola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xagr.2024.100416_bib0001","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/j.xagr.2024.100416_bib0002","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.xagr.2024.100416_bib0003","series-title":"recommendations on antenatal corticosteroids for improving preterm birth outcomes","year":"2022"},{"issue":"14","key":"10.1016\/j.xagr.2024.100416_bib0004","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xagr.2024.100416_bib0005","first-page":"138","article-title":"Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation","volume":"20","author":"Sifianou","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xagr.2024.100416_bib0006","first-page":"273","article-title":"Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis","volume":"9","author":"Star","year":"2000","journal-title":"J Maternal-Fetal Med"},{"issue":"9","key":"10.1016\/j.xagr.2024.100416_bib0007","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pd.5664","article-title":"Controversies in antenatal corticosteroid treatment","volume":"40","author":"Thevathasan","year":"2020","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1016\/j.xagr.2024.100416_bib0008","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ajog.2004.05.052","article-title":"The influence of obesity and diabetes on the prevalence of macrosomia","volume":"191","author":"Ehrenberg","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.xagr.2024.100416_bib0009","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4103\/ijem.IJEM_66_17","article-title":"Maternal and neonatal outcome in mothers with gestational diabetes mellitus","volume":"21","author":"Prakash","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.xagr.2024.100416_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1447-0756.2011.01659.x","article-title":"Gestational diabetes mellitus: a risk factor for non-elective cesarean section","volume":"38","author":"Gorgal","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"10.1016\/j.xagr.2024.100416_bib0011","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-017-4206-6","article-title":"Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012","volume":"60","author":"Billionnet","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.xagr.2024.100416_bib0012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5694\/mja16.00443","article-title":"Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control","volume":"205","author":"Abell","year":"2016","journal-title":"Med J Australia"},{"key":"10.1016\/j.xagr.2024.100416_bib0013","unstructured":"Australian Bureau of Statistics. Diabetes [Internet]. Canberra: ABS; 2020-21. Available from: https:\/\/www.abs.gov.au\/statistics\/health\/health-conditions-and-risks\/diabetes\/2020-21. Accessed November 15, 2023."},{"issue":"2","key":"10.1016\/j.xagr.2024.100416_bib0014","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100416_bib0015","series-title":"WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes","year":"2022"},{"issue":"8","key":"10.1016\/j.xagr.2024.100416_bib0016","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/1471-0528.17027","article-title":"Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74","volume":"129","author":"Stock","year":"2022","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.xagr.2024.100416_bib0017","series-title":"Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health: Clinical Practice Guidelines","year":"2015"},{"issue":"3","key":"10.1016\/j.xagr.2024.100416_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/jpm-2020-0249","article-title":"Antenatal corticosteroids and short-term neonatal outcomes in term and near-term infants of diabetic mothers. Analysis of the Qatar PEARL-peristat registry","volume":"49","author":"Ali","year":"2021","journal-title":"J Perinatal Med"},{"key":"10.1016\/j.xagr.2024.100416_bib0019","doi-asserted-by":"crossref","unstructured":"Battarbee AN, Sandoval G, Grobman WA, et al. Antenatal corticosteroids and preterm neonatal morbidity and mortality among women with and without diabetes in pregnancy. comparative study research support, N.I.H., extramural. Am J Perinatol. 39(1):67-74. doi:10.1055\/s-0040-1714391","DOI":"10.1055\/s-0040-1714391"},{"issue":"6","key":"10.1016\/j.xagr.2024.100416_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pedneo.2020.07.002","article-title":"Neonatal outcomes associated with late preterm betamethasone administration in women with pregestational diabetes","volume":"61","author":"Cassimatis","year":"2020","journal-title":"Pediatrics and Neonatology"},{"issue":"12","key":"10.1016\/j.xagr.2024.100416_bib0021","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41372-021-01267-4","article-title":"Neonatal hypoglycemia after antenatal late preterm steroids in individuals with diabetes","volume":"41","author":"Dude","year":"2021","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.xagr.2024.100416_bib0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/dc19-2126","article-title":"Complications of antenatal corticosteroids in infants born by early term scheduled cesarean section","volume":"43","author":"Gupta","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.xagr.2024.100416_bib0023","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0041-1729561","article-title":"Evaluation of hypoglycemia in neonates of women at risk for late preterm delivery: an antenatal late preterm steroids trial cohort study","volume":"40","author":"Gyamfi-Bannerman","year":"2023","journal-title":"Am J Perinatol."},{"key":"10.1016\/j.xagr.2024.100416_bib0024","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.diabres.2016.06.005","article-title":"Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes","volume":"118","author":"Jolley","year":"2016","journal-title":"Diabetes Res Clin Practice"},{"key":"10.1016\/j.xagr.2024.100416_bib0025","doi-asserted-by":"crossref","unstructured":"Kakoulidis I, Ilias I, Linardi A, Milionis C, Michou A, Koukkou E. Glycemic profile assessment during betamethasone administration in women with gestational diabetes mellitus. Observational Study. Diabetes & Metabolic Syndrome. 13(1):214-215.doi:10.1016\/j.dsx.2018.08.001","DOI":"10.1016\/j.dsx.2018.08.001"},{"issue":"4","key":"10.1016\/j.xagr.2024.100416_bib0026","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00404-018-4848-8","article-title":"Neonatal outcome in gestational-diabetic mothers treated with antenatal corticosteroids delivering at the late preterm and term","volume":"298","author":"Krispin","year":"2018","journal-title":"Arch Gynecol Obstetr"},{"issue":"2","key":"10.1016\/j.xagr.2024.100416_bib0027","first-page":"143","article-title":"Maternal glucose response to betamethasone administration","volume":"30","author":"Langen","year":"2015","journal-title":"Am J Perinatol"},{"issue":"no pagination","key":"10.1016\/j.xagr.2024.100416_bib0028","article-title":"Time interval from early-term antenatal corticosteroids administration to delivery and the impact on neonatal outcomes","volume":"10","author":"Li","year":"2022","journal-title":"Front Pediatrics"},{"issue":"9","key":"10.1016\/j.xagr.2024.100416_bib0029","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/1471-0528.16677","article-title":"Antenatal corticosteroid therapy in late preterm delivery: a nationwide population-based retrospective study in Taiwan","volume":"128","author":"Liang","year":"2021","journal-title":"BJOG: An Int J Obstetr Gynaecol"},{"issue":"3","key":"10.1016\/j.xagr.2024.100416_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ajo.12963","article-title":"Should antenatal corticosteroids be considered in women with gestational diabetes before planned late gestation caesarean section","volume":"59","author":"Paul","year":"2019","journal-title":"Australian and New Zealand J Obstetr Gynaecol"},{"key":"10.1016\/j.xagr.2024.100416_bib0031","first-page":"2927","article-title":"Neonatal hypoglycemia following late preterm antenatal corticosteroid administration in individuals with diabetes in pregnancy","volume":"41","author":"Raj-Derouin","year":"2023","journal-title":"Am J Perinatol"},{"issue":"12","key":"10.1016\/j.xagr.2024.100416_bib0032","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/1471-0528.17513","article-title":"PRECeDe Pilot: Prevention of neonatal respiratory distress with antenatal corticosteroids before elective caesarean section in women with diabetes - a feasibility randomised trial","volume":"130","author":"Said","year":"2023","journal-title":"BJOG: An Int J Obstetr Gynaecol"},{"key":"10.1016\/j.xagr.2024.100416_bib0033","doi-asserted-by":"crossref","unstructured":"Thevathasan I, Karahalios A, Unterscheider J, Leung L, Walker S, Said JM. Neonatal outcomes following antenatal corticosteroid administration prior to elective caesarean delivery in women with pre-gestational diabetes: a retrospective cohort study. Observational Study. Austr New Zealand J Obstetr Gynaecol. 63(1):93-98. doi:10.1111\/ajo.13586","DOI":"10.1111\/ajo.13586"},{"key":"10.1016\/j.xagr.2024.100416_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246175","article-title":"Maternal and neonatal glycaemic control after antenatal corticosteroid administration in women with diabetes in pregnancy: a retrospective cohort study","volume":"16","author":"Tuohy","year":"2021","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.xagr.2024.100416_bib0035","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41372-020-0589-1","article-title":"Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids","volume":"40","author":"Uquillas","year":"2020","journal-title":"J Perinatol"},{"issue":"8","key":"10.1016\/j.xagr.2024.100416_bib0036","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41372-021-01273-6","article-title":"Association of antenatal steroids with surfactant administration in moderate preterm infants born to women with diabetes mellitus and\/or hypertension","volume":"42","author":"Weydig","year":"2022","journal-title":"J Perinatol"},{"issue":"1","key":"10.1016\/j.xagr.2024.100416_bib0037","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2016.01.004","article-title":"Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort","volume":"215","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.xagr.2024.100416_bib0038","article-title":"Latency of late preterm steroid administration to delivery and risk of neonatal hypoglycemia","volume":"4","author":"McElwee","year":"2022","journal-title":"Am J Obstetr Gynecol MFM"},{"issue":"3","key":"10.1016\/j.xagr.2024.100416_bib0039","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00404-020-05785-y","article-title":"Antenatal betamethasone and the risk of neonatal hypoglycemia: it's all about timing","volume":"303","author":"Zipori","year":"2021","journal-title":"Arch Gynecol Obstetr"},{"issue":"2","key":"10.1016\/j.xagr.2024.100416_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000203337","article-title":"Hypoglycemia rates in the first days of life among term infants born to diabetic mothers","volume":"96","author":"Maayan-Metzger","year":"2009","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.xagr.2024.100416_bib0041","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/14767058.2017.1391781","article-title":"Early neonatal hypoglycemia: incidence of and risk factors. A cohort study using universal point of care screening","volume":"32","author":"Bromiker","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.xagr.2024.100416_bib0042","doi-asserted-by":"crossref","first-page":"F174","DOI":"10.1136\/fn.79.3.F174","article-title":"Long-term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancy","volume":"79","author":"Stenninger","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.xagr.2024.100416_bib0043","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1464-5491.2003.00853.x","article-title":"A protocol for improved glycaemic control following corticosteroid therapy in diabetic pregnancies","volume":"20","author":"Kaushal","year":"2003","journal-title":"Diabetic Med"},{"issue":"4","key":"10.1016\/j.xagr.2024.100416_bib0044","doi-asserted-by":"crossref","first-page":"e14489","DOI":"10.1111\/dme.14489","article-title":"Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes","volume":"38","author":"Rowe","year":"2021","journal-title":"Diabetic Medicine"},{"issue":"25","key":"10.1016\/j.xagr.2024.100416_bib0045","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1080\/14767058.2021.1900104","article-title":"Comparison of a subcutaneous versus intravenous insulin protocol for managing hyperglycemia following antenatal betamethasone in women with diabetes: a pilot randomized controlled trial. Clinical Trial Protocol","volume":"35","author":"Sweeting","year":"2022","journal-title":"J Maternal-Fetal Neonatal Med"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577824001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577824001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T23:41:03Z","timestamp":1734133263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577824001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666577824001102"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2024.100416","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal and neonatal outcomes following antenatal corticosteroids in pregnancies complicated by diabetes: a scoping review","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2024.100416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100416"}}